Evaluation of Diagnostic Serological Results in Cases of Suspected Primary Syphilis Infection

Background Reverse sequence screening for syphilis, in which an automatable treponemal assay (enzyme immunoassay [EIA]/chemiluminescence assay [CIA]) is performed first and followed by a nontreponemal test for reactive specimens, has been used increasingly in the United States. The EIA is objective, efficient, and believed to be more sensitive than the rapid plasma reagin (RPR) because treponemal antibodies appear before nontreponemal antibodies. We sought to compare the sensitivity of a commonly used EIA, the Trep-Sure EIA (TS-EIA), to the RPR in cases of suspected primary syphilis infection in our clinic. Methods A retrospective medical record review of patients with sexually transmitted infection clinic visits from January 2009 to December 2011 was conducted, and 52 patients met the following inclusion criteria: suspected primary syphilis symptoms, at least 1 positive syphilis test result at visit, and no history of syphilis. Sensitivity analyses compared the TS-EIA and RPR, using the reference standard of concordantly positive/reactive TS-EIA/RPR or positive fluorescent treponemal antibody absorption test (FTA-ABS) result. We considered equivocal TS-EIA results to be positive for sensitivity calculations because such results typically reflex to additional testing and therefore may still result in identifying new infections. Results Twenty-eight (53.8%) of the 52 patients had a positive or equivocal TS-EIA. Twenty-five (89.3%) of those were RPR reactive; the remaining 3 (10.7%) were RPR nonreactive, FTA-ABS positive. Forty patients (76.9%) had a positive RPR, including 15 patients (37.5%) with negative TS-EIA results; all 15 were FTA-ABS positive. Nine additional patients were TS-EIA negative and RPR nonreactive but had a positive FTA-ABS result. The RPR was significantly more sensitive than the EIA (76.9% vs. 53.8%, P = 0.005). Trep-Sure EIA positivity was also significantly associated with higher median RPR titer (P = 0.011). Conclusions Use of the TS-EIA may result in underdetection of primary syphilis compared with the RPR. Further evaluation of the sensitivity of the TS-EIA in high-morbidity settings is warranted before the adoption of reverse sequence screening algorithms.

[1]  G. Bolan,et al.  Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. , 2011, The Journal of infectious diseases.

[2]  M. Pandori,et al.  Evaluation of an IgM/IgG Sensitive Enzyme Immunoassay and the Utility of Index Values for the Screening of Syphilis Infection in a High-Risk Population , 2011, Sexually transmitted diseases.

[3]  M. Binnicker,et al.  Treponema-Specific Tests for Serodiagnosis of Syphilis: Comparative Evaluation of Seven Assays , 2011, Journal of Clinical Microbiology.

[4]  K. Owusu-Edusei,et al.  Serologic Testing for Syphilis in the United States: A Cost-Effectiveness Analysis of Two Screening Algorithms , 2011, Sexually transmitted diseases.

[5]  QuickStats,et al.  Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006-2010. , 2011, MMWR. Morbidity and mortality weekly report.

[6]  A. Seña,et al.  Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Ohinmaa,et al.  Cost effectiveness of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis , 2008, International journal of STD & AIDS.

[8]  Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005-2006. , 2008, MMWR. Morbidity and mortality weekly report.

[9]  J. Klausner,et al.  Syphilis and HIV infection: an update. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  R. Janssen,et al.  Syphilis Epidemics and Human Immunodeficiency Virus (HIV) Incidence Among Men Who Have Sex With Men in the United States: Implications for HIV Prevention , 2005, Sexually transmitted diseases.

[11]  Sam Ratnam,et al.  The laboratory diagnosis of syphilis. , 2005, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[12]  A. Luger,et al.  Comparative Evaluation of Nine Different Enzyme-Linked Immunosorbent Assays for Determination of Antibodies againstTreponema pallidum in Patients with Primary Syphilis , 2000, Journal of Clinical Microbiology.

[13]  H. Young,et al.  Novel Recombinant-Antigen Enzyme Immunoassay for Serological Diagnosis of Syphilis , 1998, Journal of Clinical Microbiology.

[14]  S. Larsen,et al.  Laboratory diagnosis and interpretation of tests for syphilis , 1995, Clinical microbiology reviews.